1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > 2016 Estonia Virology and Bacteriology Testing Market: Volume and Sales Forecasts for 100 Tests, Competitive Strategies, Innovative Technologies, Opportunities for Suppliers

This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the infectious disease testing market during the next five years. The report reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies.

The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs. Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Current and Emerging Products

- In-depth examination of over 100 major diseases, including their etiology, current diagnostic tests, vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease testing, including their operating characteristics, features and selling prices.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for infectious disease testing.

- Companies developing or marketing infectious disease diagnostic products by individual test.

Opportunities and Strategic Recommendations

- Emerging opportunities for new instrumentation, reagents kits, IT and other products with significant market appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

Contains 950 pages and 125 tables

Table Of Contents

2016 Estonia Virology and Bacteriology Testing Market: Volume and Sales Forecasts for 100 Tests, Competitive Strategies, Innovative Technologies, Opportunities for Suppliers
I. Introduction
II. Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. AIDS
2. Adenovirus
3. Aeromonads
4. Anthrax/Bacillus Anthracis
5. Arboviruses
6. Babesiosis
7. Bacillary Epithelioid Angiomatosis (BEA)
and other Bartonella (Rochalimaea)
8. Blastocystis Hominis
9. Brucella
10. Campylobacter
11. Candida
12. Chagas Disease
13. Chancroid
14. Chlamydia
15. Clostridium Difficile
16. Coronaviruses
17. Coxsackieviruses
18. Creutzfeldt-Jakob's Disease
19. Cryptosporidium Parvum
20. Cyclospora Cayetanensis
21. Cytomegalovirus
22. Ebola Virus
23. E. Coli
24. Echovirus
25. Encephalitis
26. Enteroviruses
27. Epstein-Barr Virus
28. Giardia Lamblia
29. Gonorrhea
30. Granuloma Inguinale
31. Hantavirus
32. Helicobacter Pylori
33. Hepatitis
34. Herpes Simplex Virus
35. Human Herpes Virus-6 (HHV-6)
36. Influenza Viruses
37. Legionella


39. Lymphogranuloma Venereum (LGV)
40. Malaria
41. Measles (Rubeola)
42. Meningitis
43. Microsporidium
44. Mononucleosis
45. Mumps
46. Mycoplasma
47. Papillomaviruses
48. Parvovirus B19
49. Pneumonia
50. Polyomaviruses
51. Pseudomonas Aeruginosa
52. Rabies
53. Respiratory Syncytial Virus (RSV)
54. Rhinoviruses
55. Rotavirus (REOVIRUS)
56. Rubella (MEASLES)
57. Salmonellosis
58. Septicemia
59. Shigellosis
60. Staphylococcus Aureus
61. Streptococci
62. Syphilis
63. Toxoplasmosis
64. Trichomonas Vaginalis
65. Tuberculosis
66. Vibrio
67. West Nile Virus
68. Yersina
B. Instrumentation Review: Operating Characteristics,
Features and Selling Princes of Leading Automated
and Semi-automated Analyzers
C. Emerging Diagnostic Technologies
III. Market Size, Growth and Sales Forecasts by Test
IV. Major Product Development Opportunities
V. Design Criteria for Decentralized Testing Products

VI. Alternative Market Penetration Strategies
VII. Distribution Strategies for Decentralized
Testing Markets
VIII. Potential Market Entry Barriers and Risks
IX. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Enzo Biochem
- Fujirebio/Innogenetics
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech
- Life Technology
- Lonza
- Nanogen/Elitech
- Novartis Diagnostics/Grifols
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako


List of Tables
All Market Segments Infectious Disease Test Volume Forecast
All Market Segments Infectious Disease Test Volume by Method
All Market Segments Infectious Disease Diagnostics Market Forecast
HIV/HIV-1/2/Combo Test Volume and Diagnostics Sales Forecast
HIV Ag Test Volume and Diagnostics Sales Forecast
Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast
Adenovirus Test Volume and Diagnostics Sales Forecast
Aeromonads Test Volume and Diagnostics Sales Forecast
BEA Test Volume and Diagnostics Sales Forecast
Blastocystis Hominis Test Volume and Diagnostics Sales Forecast
Campylobacter Test Volume and Diagnostics Sales Forecast
Candida Test Volume and Diagnostics Sales Forecast
Chancroid Test Volume and Diagnostics Sales Forecast
Chlamydia Test Volume and Diagnostics Sales Forecast
Clostridium Test Volume and Diagnostics Sales Forecast
Coronavirus Test Volume and Diagnostics Sales Forecast
Coxsackievirus Test Volume and Diagnostics Sales Forecast
Cryptosporidium Test Volume and Diagnostics Sales Forecast
CMV Test Volume and Diagnostics Sales Forecast
Cyclospora Test Volume and Diagnostics Sales Forecast
E. Coli Test Volume and Diagnostics Sales Forecast

Echovirus Test Volume and Diagnostics Sales Forecast

Encephalitis Test Volume and Diagnostics Sales Forecast
Enterovirus Test Volume and Diagnostics Sales Forecast
EBV Test Volume and Diagnostics Sales Forecast
Giardia Test Volume and Diagnostics Sales Forecast
Gonorrhea Test Volume and Diagnostics Sales Forecast
Granuloma Inguinale Test Volume and Diagnostics Sales Forecast
Hantavirus Test Volume and Diagnostics Sales Forecast
Helicobacter Pylori Test Volume and Diagnostics Sales Forecast
HBsAg Test Volume and Diagnostics Sales Forecast
Hepatitis C Test Volume and Diagnostics Sales Forecast
Anti-HBc Test Volume and Diagnostics Sales Forecast
Anti-HBs Test Volume and Diagnostics Sales Forecast
Anti-HAV Test Volume and Diagnostics Sales Forecast
Hepatitis Delta Test Volume and Diagnostics Sales Forecast
HAV NAT Test Volume and Diagnostics Sales Forecast
HBV NAT Test Volume and Diagnostics Sales Forecast
HBcAg Test Volume and Diagnostics Sales Forecast
HBeAg Test Volume and Diagnostics Sales Forecast
ALT/SGPT Test Volume and Diagnostics Sales Forecast
Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast
Herpes Type VI Test Volume and Diagnostics Sales Forecast

HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast

Influenza Test Volume and Diagnostics Sales Forecast
Legionella Test Volume and Diagnostics Sales Forecast
Lyme Disease Test Volume and Diagnostics Sales Forecast
Lymphogranuloma Test Volume and Diagnostics Sales Forecast
Malaria Test Volume and Diagnostics Sales Forecast
Measles Test Volume and Diagnostics Sales Forecast
Meningitis Test Volume and Diagnostics Sales Forecast
Microsporidium Test Volume and Diagnostics Sales Forecast
Mononucleosis Test Volume and Diagnostics Sales Forecast
Mumps Test Volume and Diagnostics Sales Forecast
Mycoplasma Test Volume and Diagnostics Sales Forecast
Papilloma Virus Test Volume and Diagnostics Sales Forecast
Parvovirus Test Volume and Diagnostics Sales Forecast
Pneumonia Test Volume and Diagnostics Sales Forecast
Polyoma Viruses Test Volume and Diagnostics Sales Forecast
Pseudomonas Test Volume and Diagnostics Sales Forecast
Rabies Test Volume and Diagnostics Sales Forecast
RSV Test Volume and Diagnostics Sales Forecast
Rhinovirus Test Volume and Diagnostics Sales Forecast
Rotavirus Test Volume and Diagnostics Sales Forecast
Rubella Test Volume and Diagnostics Sales Forecast
Salmonella Test Volume and Diagnostics Sales Forecast

Septicemia Test Volume and Diagnostics Sales Forecast
Shigella Test Volume and Diagnostics Sales Forecast
Staphylococci Test Volume and Diagnostics Sales Forecast
Streptococci Test Volume and Diagnostics Sales Forecast
Syphilis Test Volume and Diagnostics Sales Forecast
Toxoplasmosis Test Volume and Diagnostics Sales Forecast
Trichomonas Test Volume and Diagnostics Sales Forecast
Tuberculosis Test Volume and Diagnostics Sales Forecast
Vibrio Test Volume and Diagnostics Sales Forecast
Yersinia Test Volume and Diagnostics Sales Forecast
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests

Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests

Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.